CYCLERION Trademark

Trademark Overview


On Wednesday, November 21, 2018, a trademark application was filed for CYCLERION with the United States Patent and Trademark Office. The USPTO has given the CYCLERION trademark a serial number of 88202400. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by Cyclerion Therapeutics, Inc.. The CYCLERION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds, namely, preparations that stimulate guanylate cyclases (sGC), increase the concentration of nitric oxide (NO), increase the concentration of cyclic guanosine monophosphate (cGMP), upregulate the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway, or utilize a synergistic intera...
cyclerion

General Information


Serial Number88202400
Word MarkCYCLERION
Filing DateWednesday, November 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements


Description of MarkThe mark consists of the wording "CYCLERION" with an incomplete circular design element comprised of 23 separate triangular shapes positioned around the letter "C".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds, namely, preparations that stimulate guanylate cyclases (sGC), increase the concentration of nitric oxide (NO), increase the concentration of cyclic guanosine monophosphate (cGMP), upregulate the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway, or utilize a synergistic interaction of the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway with a complementary signaling pathway; Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds
Pseudo MarkC CYCLERION
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "CYCLERION" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCyclerion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameCyclerion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022SOU EXTENSION 5 GRANTED
Wednesday, August 31, 2022SOU EXTENSION 5 FILED
Wednesday, August 31, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 28, 2022SOU EXTENSION 4 GRANTED
Monday, February 28, 2022SOU EXTENSION 4 FILED
Monday, February 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 14, 2021SOU EXTENSION 3 GRANTED
Tuesday, September 14, 2021SOU EXTENSION 3 FILED
Tuesday, September 14, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 8, 2021SOU EXTENSION 2 GRANTED
Monday, March 8, 2021SOU EXTENSION 2 FILED
Monday, March 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 15, 2020SOU EXTENSION 1 GRANTED
Friday, May 15, 2020SOU EXTENSION 1 FILED
Friday, May 15, 2020SOU TEAS EXTENSION RECEIVED
Thursday, May 14, 2020CORRECTED NOA E-MAILED
Wednesday, May 13, 2020DIVISIONAL PROCESSING COMPLETE
Sunday, April 26, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, May 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, April 26, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 16, 2019EXAMINER'S AMENDMENT ENTERED
Monday, December 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2019EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 9, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 9, 2019FINAL REFUSAL E-MAILED
Tuesday, July 9, 2019FINAL REFUSAL WRITTEN
Thursday, June 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2019ASSIGNED TO LIE
Wednesday, June 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 19, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 19, 2018NON-FINAL ACTION WRITTEN
Tuesday, December 18, 2018ASSIGNED TO EXAMINER
Friday, December 14, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 24, 2018NEW APPLICATION ENTERED